Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Apr;56(4):250–265. doi: 10.1136/thorax.56.4.250

Statement on malignant mesothelioma in the United Kingdom

T British
PMCID: PMC1746025  PMID: 11254815

Full Text

The Full Text of this article is available as a PDF (186.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amesbury B., O'Riordan J., Dolin S. The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med. 1999 Mar;13(2):153–158. doi: 10.1191/026921699670764204. [DOI] [PubMed] [Google Scholar]
  2. Antman K. H., Pomfret E. A., Aisner J., MacIntyre J., Osteen R. T., Greenberger J. S. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983 Jun;1(6):386–391. doi: 10.1200/JCO.1983.1.6.386. [DOI] [PubMed] [Google Scholar]
  3. Averbach A. M., Sugarbaker P. H. Peritoneal mesothelioma: treatment approach based on natural history. Cancer Treat Res. 1996;81:193–211. doi: 10.1007/978-1-4613-1245-1_17. [DOI] [PubMed] [Google Scholar]
  4. Ball D. L., Cruickshank D. G. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol. 1990 Feb;13(1):4–9. doi: 10.1097/00000421-199002000-00002. [DOI] [PubMed] [Google Scholar]
  5. Bissett D., Macbeth F. R., Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol) 1991 Nov;3(6):315–317. doi: 10.1016/s0936-6555(05)80582-5. [DOI] [PubMed] [Google Scholar]
  6. Boutin C., Irisson M., Rathelot P., Petite J. M. L'extension pariétale des mésothéliomes pleuraux malins diffus après biopsies. Prévention par radiothérapie locale. Presse Med. 1983 Jul 9;12(29):1823–1823. [PubMed] [Google Scholar]
  7. Boutin C., Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer. 1993 Jul 15;72(2):389–393. doi: 10.1002/1097-0142(19930715)72:2<389::aid-cncr2820720213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. Boutin C., Rey F., Viallat J. R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758. doi: 10.1378/chest.108.3.754. [DOI] [PubMed] [Google Scholar]
  9. Bredin M., Corner J., Krishnasamy M., Plant H., Bailey C., A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999 Apr 3;318(7188):901–904. doi: 10.1136/bmj.318.7188.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Browne K., Smither W. J. Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites. Br J Ind Med. 1983 May;40(2):145–152. doi: 10.1136/oem.40.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bruera E. Pharmacological treatment of cachexia: any progress? Support Care Cancer. 1998 Mar;6(2):109–113. doi: 10.1007/s005200050143. [DOI] [PubMed] [Google Scholar]
  12. Butchart E. G., Ashcroft T., Barnsley W. C., Holden M. P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976 Feb;31(1):15–24. doi: 10.1136/thx.31.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cowap J., Hardy J. Thioridazine in the management of cancer-related sweating. J Pain Symptom Manage. 1998 May;15(5):266–266. [PubMed] [Google Scholar]
  14. Davis S. R., Tan L., Ball D. L. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol. 1994 Aug;38(3):212–214. doi: 10.1111/j.1440-1673.1994.tb00177.x. [DOI] [PubMed] [Google Scholar]
  15. Elmes P. C., Simpson J. C. The clinical aspects of mesothelioma. Q J Med. 1976 Jul;45(179):427–449. [PubMed] [Google Scholar]
  16. Gardner M. J., Jones R. D., Pippard E. C., Saitoh N. Mesothelioma of the peritoneum during 1967-82 in England and Wales. Br J Cancer. 1985 Jan;51(1):121–126. doi: 10.1038/bjc.1985.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gordon W., Jr, Antman K. H., Greenberger J. S., Weichselbaum R. R., Chaffey J. T. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):19–25. doi: 10.1016/0360-3016(82)90379-0. [DOI] [PubMed] [Google Scholar]
  18. Heelan R. T. CT and MR imaging in the evaluation of pleural masses. Chest Surg Clin N Am. 1994 Aug;4(3):431–450. [PubMed] [Google Scholar]
  19. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983 Oct;77(4):321–343. [PubMed] [Google Scholar]
  20. Hubbard R. The aetiology of mesothelioma: are risk factors other than asbestos exposure important? Thorax. 1997 Jun;52(6):496–497. doi: 10.1136/thx.52.6.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jackson M. B., Pounder D., Price C., Matthews A. W., Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax. 1999 Mar;54(3):238–241. doi: 10.1136/thx.54.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kannerstein M., Churg J. Peritoneal mesothelioma. Hum Pathol. 1977 Jan;8(1):83–94. doi: 10.1016/s0046-8177(77)80067-1. [DOI] [PubMed] [Google Scholar]
  23. Kennedy L., Sahn S. A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994 Oct;106(4):1215–1222. doi: 10.1378/chest.106.4.1215. [DOI] [PubMed] [Google Scholar]
  24. Law M. R., Hodson M. E., Heard B. E. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982 Nov;37(11):810–815. doi: 10.1136/thx.37.11.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Layer G., van Kaick G. Mesotheliom der Pleura--Diagnostik durch bildgebende Verfahren. Langenbecks Arch Chir Suppl Kongressbd. 1992:173–179. [PubMed] [Google Scholar]
  26. Leung A. N., Müller N. L., Miller R. R. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990 Mar;154(3):487–492. doi: 10.2214/ajr.154.3.2106209. [DOI] [PubMed] [Google Scholar]
  27. Low E. M., Khoury G. G., Matthews A. W., Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol (R Coll Radiol) 1995;7(5):317–318. doi: 10.1016/s0936-6555(05)80540-0. [DOI] [PubMed] [Google Scholar]
  28. McDonald J. C. Health implications of environmental exposure to asbestos. Environ Health Perspect. 1985 Oct;62:319–328. doi: 10.1289/ehp.8562319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McGavin C., Hughes P. Finger clubbing in malignant mesothelioma and benign asbestos pleural disease. Respir Med. 1998 Apr;92(4):691–692. doi: 10.1016/s0954-6111(98)90519-4. [DOI] [PubMed] [Google Scholar]
  30. McLoud T. C. CT and MR in pleural disease. Clin Chest Med. 1998 Jun;19(2):261–276. doi: 10.1016/s0272-5231(05)70076-9. [DOI] [PubMed] [Google Scholar]
  31. Middleton G. W., Smith I. E., O'Brien M. E., Norton A., Hickish T., Priest K., Spencer L., Ashley S. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Ann Oncol. 1998 Mar;9(3):269–273. doi: 10.1023/a:1008236010868. [DOI] [PubMed] [Google Scholar]
  32. Moertel C. G. Peritoneal mesothelioma. Gastroenterology. 1972 Aug;63(2):346–350. [PubMed] [Google Scholar]
  33. Ong S. T., Vogelzang N. J. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol. 1996 Mar;14(3):1007–1017. doi: 10.1200/JCO.1996.14.3.1007. [DOI] [PubMed] [Google Scholar]
  34. Pass H. I., Temeck B. K., Kranda K., Thomas G., Russo A., Smith P., Friauf W., Steinberg S. M. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997 Dec;4(8):628–633. doi: 10.1007/BF02303746. [DOI] [PubMed] [Google Scholar]
  35. Patz E. F., Jr, Shaffer K., Piwnica-Worms D. R., Jochelson M., Sarin M., Sugarbaker D. J., Pugatch R. D. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol. 1992 Nov;159(5):961–966. doi: 10.2214/ajr.159.5.1414807. [DOI] [PubMed] [Google Scholar]
  36. Peto J., Hodgson J. T., Matthews F. E., Jones J. R. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995 Mar 4;345(8949):535–539. doi: 10.1016/s0140-6736(95)90462-x. [DOI] [PubMed] [Google Scholar]
  37. Peto J., Seidman H., Selikoff I. J. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982 Jan;45(1):124–135. doi: 10.1038/bjc.1982.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Renshaw A. A., Dean B. R., Antman K. H., Sugarbaker D. J., Cibas E. S. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997 Jan;111(1):106–109. doi: 10.1378/chest.111.1.106. [DOI] [PubMed] [Google Scholar]
  39. Reuter K., Raptopoulos V., Reale F., Krolikowski F. J., D'Orsi C. J., Graham S., Smith E. H. Diagnosis of peritoneal mesothelioma: computed tomography, sonography, and fine-needle aspiration biopsy. AJR Am J Roentgenol. 1983 Jun;140(6):1189–1194. doi: 10.2214/ajr.140.6.1189. [DOI] [PubMed] [Google Scholar]
  40. Ribak J., Selikoff I. J. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med. 1992 Oct;49(10):732–735. doi: 10.1136/oem.49.10.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rusch V. W. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer. 1996 Feb;14(1):1–12. doi: 10.1016/0169-5002(95)00508-0. [DOI] [PubMed] [Google Scholar]
  42. Rusch V. W., Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996 Apr;111(4):815–826. doi: 10.1016/s0022-5223(96)70342-2. [DOI] [PubMed] [Google Scholar]
  43. Ryan C. W., Herndon J., Vogelzang N. J. A review of chemotherapy trials for malignant mesothelioma. Chest. 1998 Jan;113(1 Suppl):66S–73S. doi: 10.1378/chest.113.1_supplement.66s. [DOI] [PubMed] [Google Scholar]
  44. Sugarbaker D. J., Flores R. M., Jaklitsch M. T., Richards W. G., Strauss G. M., Corson J. M., DeCamp M. M., Jr, Swanson S. J., Bueno R., Lukanich J. M. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan;117(1):54–65. doi: 10.1016/s0022-5223(99)70469-1. [DOI] [PubMed] [Google Scholar]
  45. Sugarbaker D. J., Garcia J. P., Richards W. G., Harpole D. H., Jr, Healy-Baldini E., DeCamp M. M., Jr, Mentzer S. J., Liptay M. J., Strauss G. M., Swanson S. J. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996 Sep;224(3):288–296. doi: 10.1097/00000658-199609000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Upham J. W., Garlepp M. J., Musk A. W., Robinson B. W. Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax. 1995 Aug;50(8):887–893. doi: 10.1136/thx.50.8.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Van Gelder T., Damhuis R. A., Hoogsteden H. C. Prognostic factors and survival in malignant pleural mesothelioma. Eur Respir J. 1994 Jun;7(6):1035–1038. [PubMed] [Google Scholar]
  48. Walker-Renard P. B., Vaughan L. M., Sahn S. A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994 Jan 1;120(1):56–64. doi: 10.7326/0003-4819-120-1-199401010-00010. [DOI] [PubMed] [Google Scholar]
  49. Waller D. A., Morritt G. N., Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995 May;107(5):1454–1456. doi: 10.1378/chest.107.5.1454. [DOI] [PubMed] [Google Scholar]
  50. Whitaker D., Shilkin K. B. Diagnosis of pleural malignant mesothelioma in life--a practical approach. J Pathol. 1984 Jul;143(3):147–175. doi: 10.1002/path.1711430303. [DOI] [PubMed] [Google Scholar]
  51. Yates D. H., Corrin B., Stidolph P. N., Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 1997 Jun;52(6):507–512. doi: 10.1136/thx.52.6.507. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Correction]
thorax_56_4_250__index.html (1.3KB, html)

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES